Position in ZTS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$316,686
-$1,006,437 QoQ
Shares Held
4,407
-60.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#903
of 1,408 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST HORIZON CORP holds $758,463 across 10 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (41.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
4,407 | $316,686 | |
| 2 | HLN |
Haleon plc
|
20,921 | $195,192 | |
| 3 | VTRS |
Viatris Inc
|
7,472 | $118,654 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,116 | $37,810 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
330 | $36,609 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
458 | $21,301 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
123 | $20,730 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
21 | $11,378 |
All Filings in ZTS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,686 | 4,407 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $1,323,123 | 11,193 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $1,494,615 | 11,879 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $2,044,235 | 13,971 | Shares | Defined | 2025-10-27 | |
| 2021-06-30 | $9,474,169 | 50,838 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $8,260,928 | 52,457 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $8,469,959 | 51,178 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $7,964,715 | 48,163 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||